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Migrationokine induced by the interferon-γ (MIG) has been shown in HBV carriers, and it is
involved in the inﬁltration of inﬂammatory cells and liver damage after HBV infection. However, the
molecular mechanisms by which HBV-induced MIG expression have not been characterized. Our results
indicated that HBx protein induced MIG expression in a dose-dependent manner. Such increase was due to
the direct binding of NF-κB to the MIG promoter. By luciferase, chromatin immunoprecipitation and
electrophoretic mobility shift assays, we demonstrated that the NF-κB binding site at positions −147 was
essential for transcriptional activation of MIG promoter by HBx protein. Chemotaxis assay showed that the
up-regulation of MIG protein levels enhanced the migration of peripheral blood lymphocytes (PBLs), and
inhibition of NF-κB signiﬁcantly decreased the chemotaxis activity. Our ﬁndings provide a new insight into
how leukocytes migrate to liver, and disclose a new regulatory mechanism of MIG expression after HBV
infection.
© 2008 Published by Elsevier Inc.Introduction
The hepatitis B virus is a noncytopathic hepatotropic DNA virus
that causes acute and chronic liver diseases, which are characterized
by inﬁltration of inﬂammatory cells to liver (Chisari and Ferrari, 1995).
HBV is not directly cytopathic for the hepatocyte, the immune
response to viral antigens is thought to be responsible for both liver
disease and viral clearance after HBV infection (Maini et al., 2000).
HBV encodes a small genome, consisting of a partially double-
stranded, circular DNA that is encapsidated within an enveloped
particle (Summers et al., 1975). The HBV genome consists of four
overlapping open reading frames encoding the DNA polymerase, the
HBV surface antigen (also known as surface antigens), the HBV core
protein which comprises the viral capsid, and the nonstructural
regulatory protein known as HBx. Among these, HBx is considered as
one of the most important determinants in viral replication and the
virus-mediated pathogenesis (Bouchard and Schneider, 2004).
The HBx protein is a small protein, composed of 154 amino acids.
HBx is distributed in cytoplasm but to some extent in nucleus (Diao
et al., 2001; Murakami, 2001). Numerous studies have demonstrated
that HBx activates the transcription of several genes associated withlsevier Inc.inﬂammation, tumorigenesis, and viral replication (Bouchard and
Schneider, 2004). Several responsive elements have been reported to
bepossible sites of transactivationbyHBxprotein includingAP-1, NF-κB
and HIF-1 (Moon et al., 2004). HBx might also directly interact with
components of the basal transcription machinery, such as ribosome
binding protein 5, TATA-binding protein and the transcriptional
activator CREB/ATF (Bouchard et al., 2006; Cougot et al., 2007). This
provides another mechanism by which HBx stimulates transcription
and possibly HBV replication.
Chemokines constitute a family of small, secretory proteins that are
expressed constitutively or in an inducible manner. Their main
functions are to attract leukocytes to sites of infection and inﬂammation
and to contribute to the homeostatic circulation of leukocytes (Zlotnik
andYoshie, 2000; Rossi andZlotnik, 2000).Most chemokines share four
cysteine residues that are thought to be crucial for the tertiary structure
of the proteins. Chemokines have been divided into four different
families (C-X-C, CC, CX3C, and C) depending on the position of the ﬁrst
two cysteine residues (Zlotnik and Yoshie, 2000; Rossi and Zlotnik,
2000). MIG belongs to the CXC chemokine subfamily. The receptor for
MIG, CXCR3, is functionally expressed on activated T and B cells, NK
cells and endothelial cells (Liao et al., 1995; Romagnani et al., 2001).
MIG, which is induced by IFN-γ in macrophages, is implicated in
chronic inﬂammation and viral infections, as well as T-cell trafﬁcking,
chemotaxis, and activation (Asensio and Campbell, 1997; Loetscher
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granulation and remodeling by inhibiting angiogenesis (Strieter et al.,
1995).
NF-κB belongs to the Rel family of transcription factors, which
regulates an exceptionally large number of genes, particularly those
involved in immune and inﬂammatory responses (Chen and Greene,
2004; Hayden and Ghosh, 2004; Karin and Ben-Neriah, 2000). The
NF-κB family consists of ﬁve structurally related proteins (RelA/p65,
c-Rel, RelB, p50/p105, and p52/p100) that share an approximately
300-amino acid NH2-terminal Rel homology domain that contains
sequences essential for dimerization, DNA binding, and nuclear
transport. Family members RelA/p65, c-Rel and RelB have COOH-
terminal transactivation domains, while p50/p105 and p52/p100
function as short DNA binding proteins (Karin et al., 2002). NF-κB
subunits are able to homo- or heterodimerize to form a transcription
factor, and different NF-κB dimers exhibit different binding afﬁnities
for NF-κB sites bearing the consensus sequence GGGRNNYYCC, where
R is purine, Y is pyrimidine, and N is any base (Miyamoto and Verma,
1995). The most widely studied form of NF-κB is a heterodimer
composed of p50 and p65 subunits containing a potent transactivator
function (Schmitz and Baeuerle, 1995).
In this report, we explored the underlying molecular mechanisms
for HBx-induced MIG expression and leukocytes migration. Our data
showed that HBx protein directly induced the expression ofMIG, and a
NF-κB binding site in the MIG core promoter region was critical for
HBx-induced MIG expression. Furthermore, our study identiﬁed a
critical role that NF-κB plays in the HBx-induced leukocyte migration.
Results
HBx induces MIG gene expression in hepatocytes
To investigate the effect of HBV on the MIG expression, the
plasmid pBlue-HBV containing 1.3-fold HBV genome were transfected
into HepG2 cells, and the protein levels of MIG in the supernatants
were measured 48 h after the transfection by ELISA. It was found that
MIG protein levels signiﬁcantly increased in cells transfected with
pBlue-HBV comparedwith the cells transfected with control plasmids.
Next, we transfected a series of plasmids containing individual seven
viral genes of HBV (pCMV-S, pCMV-preS1, pCMV-preS2, pCMV-HBe,
pCMV-HBc, pCMV-HBx or pCMV-HBp) or control plasmids (pCMV-
tag2) into HepG2 cells, respectively. It was found that MIG protein
levels increased in cells transfectedwith pCMV-HBx (Fig.1B), while the
rest of the constructs for viral proteins (S, preS1, preS2, HBe,HBc, P) had
no signiﬁcant effects onMIG protein expression.
To determine whether protein encoded by HBV induces MIG gene
transcription, a construct containing the sequence from −983 to +33
(relative to the transcriptional start site) of 5′-ﬂanking region of the
human MIG gene was co-transfected with individual genes of HBV or
control plasmids, respectively, into HepG2 cells. Fig. 1C showed that
MIG promoter activity was signiﬁcantly activated by HBx protein.
Next, we examined whether the observed effects may be cell type
dependent. The ELISA and luciferase assay demonstrated that the
expression and promoter activities ofMIG gene were activated by HBV
and HBx protein in Huh-7 cells (Supplement 1 and 2).
HBx induces MIG promoter activity in a dose-dependent manner
We next investigated the dose-dependence of HBx on MIG
promoter activity in HepG2 cells. HepG2 cells were co-transfected
with theMIG promoter reporter plasmids and increased concentration
of pCMV-HBx plasmids, and then the luciferase activity wasmeasured.
It was found that the levels of luciferase activity increased as the
concentration of plasmids pCMV-HBx increased, indicating that the
activation of MIG promoter by HBx protein was concentration-
dependent (Fig. 1D). The protein levels of HBx in the transfectedHepG2 cells were measured by Western blot using anti-Flag antibody
(Fig. 1E). However, the level of luciferase activity remained relatively
unchanged when increased concentration of the other HBV genes
were transfected into the cells (data not shown).
NF-κB binding element is involved in the induction of MIG by HBx protein
Analysis of the 5′-ﬂanking sequence of MIG gene using Gene2Pro-
moter software revealed the presence of many consensus cis-elements
including NF-κB, AP-1, ISRE, and C/EBP binding sites on the MIG
promoter (Fig. 2A). Since our results showed that HBx protein
activated the transcription of MIG, we investigated the roles of these
cis-elements in the regulation of HBx-inducedMIG gene transcription.
The reporter constructs containing serial 5′ deletions of the MIG
promoter were co-transfected with pCMV-HBx, respectively, into
HepG2 cells, and luciferase activity was measured 48 h after the
transfection. As shown in Fig. 2B, deletion from nt −983 to −185 did
not affect HBx-induced luciferase activity. Further deletion to nt −129
signiﬁcantly decreased HBx-induced luciferase activity. These data
indicated that the sequence between nt −185 and −129 was critical for
the activation of MIG promoter by HBx protein. Analysis of the
promoter of MIG gene revealed that there were two NF-κB binding
sites on these regions. To investigate the role of the two NF-κB binding
sites onMIG activation, these twoNF-κB sites (NF-κB1, andNF-κB2) and
a C/eBP site near the NF-κB2 were mutated by multiple rounds of PCR.
As shown in Fig. 2C,mutation of the NF-κB1 and C/eBP binding sites did
not signiﬁcantly affect HBx-induced promoter activity, while mutation
of NF-κB2 signiﬁcantly abolished HBx-induced MIG activation. These
results suggested that the NF-κB2 binding site was required for the
HBx-induced activation ofMIG promoter.
HBx-induced MIG gene expression requires NF-κB activation
To determine the roles of NF-κB in the HBx-induced activation of
MIG promoter, pCMV-HBx and (−983/+33)MIG were co-transfected
intoHepG2 cells and then the cellswere treatedwithMG-132 (anNF-κB
inhibitor) at different concentrations (Zhang et al., 2007). Luciferase
activity assay revealed that the MIG promoter activity was gradually
inhibited as the concentrations of MG-132 were increased (Fig. 3A),
indicating that NF-κB was required for the HBx-induced activation of
MIG promoter.
HBx induces translocation of NF-κB subunits into the nucleus
NF-κB is composed of homo- and heterodimers of Rel family
members, typically p65:p50 heterodimers (Schmitz and Baeuerle,
1995). NF-κB activation results from the phosphorylation of IκB, which
targets it for ubiquitylation and degradation by the 26S proteasome.
After the destruction of IκB, NF-κB then translocates to the nucleus and
activates target genes (Malek et al., 1998; Simeonidis et al., 1999). We
examined the effect of HBx protein on the translocation of p65 from
cytosol to nucleus by transfection of HepG2 cells with pCMV-HBx. At 0,
24, and 48 h post-transfection, protein levels of p65 in the cytosol and
nucleus fractions were analyzed by Western blot using anti-p65
antibody. Results clearly revealed that the protein levels of p65
decreased in cytosol and increased innucleus as the timeof transfection
increased in cells transfected with pCMV-HBx (Fig. 3B). However, the
protein levels of p65 were relatively unchanged in both cytosol and
nucleus as the time of transfection increased in cells transfected with
pCMV-Tag2 (data not shown). These results suggested that HBx protein
facilitates the translocation of p65 from the cytosol to the nucleus.
NF-κB binds to the promoter of MIG
To determine whether NF-κB binds to the MIG promoter after
transfection with pCMV-HBx, EMSA was performed using a biotin-
Fig.1.MIG is inducedbyHBxprotein inHepG2 cells. (A, B)HepG2 cellswere transfectedwithplasmids containing 1.3-foldHBVgenome (A) or plasmids expressing differentHBVproteins
(B), respectively. The protein levels ofMIGwere analyzed by ELISA. Results shown aremean±S.D. of three experiments performed in duplicate. (C) HepG2 cells were co-transfectedwith
plasmids expressing different HBV proteins, respectively, and the reporter plasmids inwhich the luciferase gene are under the control ofMIG promoter. Relative luciferase activity was
determined by standard procedures. The luciferase activity of the cells co-transfected with pCMV-Tag2 and (−983/+33)MIG is set to 100%. Results shown are mean±S.D. of three
experiments performed in duplicate. (D, E) HepG2 cells were co-transfected with increased amount of plasmids expressing HBx protein, and the reporter plasmids (−983/+33)MIG.
Relative luciferase activity was determined by standard procedures. The luciferase activity of the cells co-transfected with pCMV-Tag2 and (−983/+33)MIG is set to 100%. Results shown
are mean±S.D. of three experiments performed in duplicate (D). The protein levels of HBx were determined by Western blot with anti-Flag antibody (E).
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to −127) as a probe. HepG2 cells were transfected with control
plasmids or pCMV-HBx, and the nuclear extracts were incubated with
the biotin-labeled probe at room temperature. As shown in Fig. 4A, the
DNA binding activity of NF-κB was signiﬁcantly increased in the cells
transfected with pCMV-HBx, compared with the HepG2 cells
transfected with control plasmids. To determine the speciﬁcity of
NF-κB binding activity, nuclear extracts were incubated with the
labeled NF-κB consensus oligonucleotides in the presence of either an
unlabeled wild type NF-κB binding probe or a mutated probe. As
shown in Fig. 4A, the wild type NF-κB consensus oligonucleotides, but
not the mutated oligonucleotides signiﬁcantly abrogated NF-κB
complexes. We conﬁrmed the authenticity of the NF-κB band using
supershift assay by incubation of nuclear extracts with antibody
against p50, p65, p52, c-Rel or RelB. As shown in Fig. 4B, incubation of
the nuclear extracts with the antibody either the p50 or the p65
supershifted the speciﬁc retardation signal, suggesting that the band
represented a p65/p50 heterodimer. We also examined the effect of
MG-132 on HBx-induced NF-κB DNA binding activity. The DNAbinding activity of NF-κB was signiﬁcantly inhibited by the treatment
with MG-132 (Fig. 4A).
We next performed a ChIP assay to determine whether NF-κB
binds to the MIG promoter in vivo. Chromatin fragments were
prepared from HepG2 cells transfected with pCMV-HBx and immuno-
precipitatedwith antibodies against either the p50 or the p65 subunit.
A 156-bp DNA fragment containing the NF-κB binding site in MIG
promoter was ampliﬁed by PCR using speciﬁc primers. Results showed
that PCR products were only produced from DNA isolated from cells
transfected with pCMV-HBx in the presence of anti-p50 or anti-p65
antibody, but they were not detected in the presence of control
plasmids and control antibody (Fig. 4C). These data indicate the NF-κB
binds to the NF-κB2 binding site on the MIG promoter.
NF-κB subunits increase the transcriptional activity of MIG
To investigate the effect of p50 and p65 subunits of NF-κB on the
transcriptional activation of MIG, HepG2 cells were co-transfected
with plasmids expressing p65 or p50 and the reporter plasmids
338 L.-M. Xia et al. / Virology 385 (2009) 335–342(−495/+33)MIG or the mutant plasmids NF-κB2 Mut. Luciferase
activity assays showed that the transcriptional activity of MIG was
elevated in the presence of p50 or p65 protein when compared to
that of control (Fig. 5A). The transcriptional activity of MIG reachedFig. 2. Involvement of NF-κB binding site in HBx-induced MIG expression. (A) Sequence a
revealed several transcription factor binding sites, including consensus sequences for NF-κ
indicated in the ﬁgure. (B) serial deletions of the 5′-ﬂanking region of the humanMIG gene w
determined. On the left was a schematic representation of the reporter gene constructs, and
each of the transfected samples. The positions of transcription factor binding sites were also
and indicated report plasmids is set to 100%, respectively.) (C) Effects of HBx protein on the
plasmids and mutations of the MIG promoter, respectively. The luciferase activity of the
respectively. Results shown are mean±S.D. of three experiments performed in duplicate.the highest level when both p50 and p65 protein were present.
However, the mutation of NF-κB2 binding site of MIG promoter
abolished the effect of p50 and/or p65 protein on the activation of
the MIG promoter.nalysis of the 5′-ﬂanking region of the human MIG gene by Gene2Promoter software
B, AP-1, ISRE and C/eBP. The transcription start site and translation start site were also
ere co-transfected into HepG2 cells with pCMV-HBx, and relative luciferase activity was
on the right side the bar graphs represented the relative levels of luciferase activity in
showed on the left. (The luciferase activity of the cells co-transfected with pCMV-Tag2
mutations of the MIG promoter. HepG2 cells were co-transfected with HBx expression
cells co-transfected with pCMV-Tag2 and indicated report plasmids is set to 100%,
Fig. 3.NF-κB is necessary for HBx-inducedMIG gene transcription. (A) HepG2 cells were
co-transfected with pCMV-HBx and the reporter plasmid (−983/+33)MIG followed by
the treatment with MG-132 at different concentrations as indicated for 48 h. Treated
cells were then lyzed and luciferase activity was measured. (The luciferase activity of
the cells co-transfected with pCMV-Tag2 and (−983/+33)MIG is set to 100%). Results
shown are mean±S.D. of three experiments performed in duplicate. (B) HepG2 cells
were transfected with pCMV-HBx. Cytosol and nucleus fractions of transfected cells
were prepared at different time as indicated. Levels of cytosolic and nuclear p65 protein
were determined by Western blot using anti-p65 antibody.
Fig. 4. NF-κB binds to theMIG promoter. (A) HepG2 cells were transfected with pCMV-
HBx or control vector for 48 h. Nuclear extracts with or without indicated concentration
of MG-132 were subjected to EMSA for DNA binding activity of NF-κB with the biotin-
labeled oligonucleotides in the absence and presence of indicated folds of unlabeled
competitors or unlabeled mutated competitors. The arrow indicates NF-κB-speciﬁc
DNA–protein complexes. (B) HepG2 cells were transfected with pCMV-HBx or control
vector for 48 h. Nuclear extractswere incubatedwith the biotin-labeled oligonucleotides
followed by incubation either with anti-p50, anti-p65, anti-p52, anti-c-Rel or anti-RelB
antibody for an additional 30 min. The arrow indicates NF-κB-speciﬁc DNA–protein
complexes. (C) ChIP assay was performed by using an antibody to p50, p65 or a control
antibody to pull down a 156-bp DNA fragment containing the NF-κB2 in the MIG
promoter fromHepG2 cells transfectedwith pCMV-HBx or control vector. Ampliﬁcation
of the input DNA is also showed.
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cells, and the protein levels ofMIGwere measured by ELISA. As shown
in Fig. 5B, p50 or p65 protein up-regulated the expression of the MIG
protein, and co-transfection with p50 and p65 further increased
protein levels of MIG. These results indicate that the p65/p50
heterodimer probably inducesMIG expression.
HBx-induced MIG increases migration of PBLs
To assess the functionality of the induced MIG protein, we
performed migration assay using activated PBLs. HepG2 cells were
transfected with plasmids expressing HBx, p50, or p65, with or
without treatment with anti-MIG antibody, and chemotatic activity of
supernatants were determined. With the 4-h time frame of the
experiment, minimal migration of PBLs was observed in response to
supernatants from HepG2 cells transfected with control plasmids. In
response to supernatants from cells transfected with plasmids
expressing HBx, p50, or p65, the migratory activity of PBLs was
substantially increased (Fig. 6). Interestingly, this activity was
signiﬁcantly decreased upon the addition of neutralizing anti-MIG
antibody to the supernatants of transfected HepG2 cells, whereas a
control antibody had little effect on migration. Treatment with NF-κB
inhibitor MG-132 after transfection with pCMV-HBx also signiﬁcantly
decreased the chemotactic activity. These ﬁndings suggest that NF-κB
activation is involved in HBx-induced chemotaxis.
Discussion
HBV infection recruits many host-derived, antigen-nonspeciﬁc
and antigen-speciﬁc polymorphonuclear and mononuclear cells (i.e.,
NK and NKT cells, T and B lymphocytes, monocytes, macrophages,
dendritic cells) into the liver that contribute to the formation of
inﬂammatory foci (Ando et al., 1994; Kakimi et al., 2001; Sitia et al.,
2002). The recruitment of necroinﬂammatory cells has been shownto be chemokine-dependent (Kakimi et al., 2001). However, the
molecular mechanisms by which HBV regulates chemokines
expression remain unknown. In the present study, we demonstrated
that the HBx protein induced MIG expression in the hepatocytes
and that HBx-induced transcription of MIG was mediated by
activation of NF-κB. Furthermore, the HBx-induced MIG could
attract inﬂammatory cells in vitro.
Chemokines are often released from activated macrophages in
inﬂammatory process and viral infection (Luster, 2002). IFN-γ, an
important regulator of macrophage function, induces the CXC
chemokines, includingMIG and IP-10, in mouse macrophages (Horton
et al., 1998). However, it was also demonstrated that MIG and IP-10
Fig. 6. HBx-induced MIG increases the chemotaxis. HepG2 cells were transfected with
indicated plasmids. After 48 h, supernatants from transfected cells were added to the
lower chamber of Transwell plates in the presence of neutralizing anti-MIG antibody or
control antibody, and activated PBLs were placed in the upper chamber. After 4 h
incubation, the number of migrated cells was counted in three randomly selected ﬁelds
per well. The number of migrated cells in response to supernatants from HepG2 cells
transfected with pCMV-Tag2 is set to 100%. Results shown are mean±S.D. of three
experiments performed in duplicate.
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ﬁbroblasts (Luﬁtg et al., 2004; Kutsch et al., 2000; Ishiguro et al., 2004;
Borgland et al., 2000). To investigate the mechanisms by which HBV
regulates MIG expression, seven viral genes of HBV were transfected
intoHepG2 cells. It was found that HBx protein activatedMIGpromoter
and induced its expression in a dose-dependent manner. These results
indicated that HBx protein was capable of inducing MIG expression
directly. Transcription activation of MIG and IP-10 is ultimately
dependent on the activation of the cis-elements in their promoter.
IFN-γ-induced expression of MIG and IP-10 is mediated by the
transcriptional factor, signal transducer and activator of transcription
α (STAT1α), which bind to the ISRE site of the MIG promoter (Horton
et al., 2002), while viral proteins are able to induce IP-10 and MIG
expression by binding toNF-κB site (Kutsch et al., 2000; Borgland et al.,
2000). To investigate the molecular mechanisms of MIG expression
induced by HBx protein, a series of deletional mutations of MIG
promoter assaywereperformed.Our results showed that the promoter
region between −185 and −129 was critical for transcriptional
activation of MIG promoter by HBx protein. Analysis of MIG promoter
by software revealed that there were two NF-κB binding sites in this
region. Site-directed mutagenesis demonstrated that the NF-κB2
binding site, but not the NF-κB1 binding site on MIG promoter was
responsible for transcriptional activation of MIG gene by HBx protein.
NF-κB is a transcriptional factor that regulates expression of genes
involved in inﬂammation, angiogenesis, chemotaxis, and cell survival
(Chen and Greene, 2004; Miyamoto and Verma, 1995). In resting cells,
NF-κB proteins are predominantly cytoplasmic, associated with a
family of inhibitory proteins termed the IκBs. IκBs were originally
thought to sequester NF-κB in the cytoplasm by masking its nuclear
localization sequences (NLSs). Activation of NF-κB classically depends
on phosphorylation of the IκBs protein. Recruitment and activation of
the classical IκB-kinase (IKK) complex (including IKKα and IKKβ) leadFig. 5.NF-κB subunits increase the expression ofMIG. (A) HepG2 cellswere co-transfected
with (−495/+33)MIG or NF-κB2 Mut reporter constructs and p65 or p50 expression
constructs, respectively. Luciferase activity was measured 48 h after transfected. The
luciferase activity of the cells co-transfected with pCMV-Tag2 and indicated report
plasmids is set to 100%, respectively. Results shown are mean±S.D. of three experiments
performed in duplicate. (B) HepG2 cells were transfectedwith p65 and/or p50. After 48 h,
the protein levels of MIG in the supernatants from transfected cells were measured by
ELISA. Results shown are mean±S.D. of three experiments performed in duplicate.to serine phosphorylation of IκB and subsequent degradation via the
proteasome pathway (Malek et al., 1998; Simeonidis et al., 1999). In
the present study, we found that p65 translocated from cytoplast to
nucleus after transfected with pCMV-HBx into HepG2 cells. EMSA and
ChIP assays revealed that the heterodimers of p50 and p65 bound to
MIG promoter and were involved in HBx-induced MIG expression.
Interestingly, overexpression of wild type p50 and p65 stimulatedMIG
expression, and inhibition of NF-κB activation by NF-κB inhibitor MG-
132 signiﬁcantly suppressed MIG expression. These data indicated
that NF-κB was activated by HBx protein and it was a critical mediator
of HBx-inducedMIG transcription. It has been demonstrated that HBx
protein is able to activate signal transduction cascades, including the
mitogen-activated protein kinase (MAPK), proline-rich tyrosine kinase
2 (Pyk2) and Src tyrosine kinases, thereby resulting in the activation of
transcription factors including AP-1, NF-κB, and NF-AT and regulation
of gene expression (Diao et al., 2001). However, the detailed signal
transduction pathway involved in the HBx-induced activation of MIG
expression is unknown and need to been further investigated.
MIG attracts leukocytes to sites of infection and inﬂammation, and
it shares the receptor CXCR3 with IP-10 (Shahabuddin et al., 2006). It
has been demonstrated that evaluated expression levels of MIG and
IP-10 were found in the individuals carrying HBV (Bieche et al., 2005).
Blocking MIG and IP-10 by speciﬁc antibodies in HBV transgenic mice
signiﬁcantly decreased the migration of mononuclear cells and
mitigated the severity of liver disease induced by HBV-speciﬁc CTLs
(Kakimi et al., 2001). The association of alleviated liver disease with
loweredMIG and IP-10 levels implies that these chemokines may play
an important part in leukocyte migration and development of liver
disease after HBV infection. To investigate the role of MIG in the
migration of leukocytes in vitro, a speciﬁc antibody was used to block
MIG. Chemotaxis analysis showed that the chemotaxis activity was
increased in cells transfected with pCMV-HBx plasmids, and blocking
MIG signiﬁcantly decreased the number of migration cells. These
results indicated thatMIG expression induced by HBx proteinwas able
to regulate the migration of leukocytes in vitro. Furthermore, the
chemotatic activity was shown to be increased in the cells transfected
with p65 or/and p50 expression vector, while NF-κB inhibitor MG-132
signiﬁcantly decreased the chemotaxis activity. These data indicated
that NF-κB was a critical mediator of HBx-induced MIG gene
transcription and chemotaxis.
In conclusion, we demonstrate that HBx protein encoded by HBV
induces expression of MIG directly in hepatocytes, and binding of
NF-κB to the NF-κB2 site in the MIG promoter is important for
transcriptional activation of MIG by HBx. Our results also suggest
341L.-M. Xia et al. / Virology 385 (2009) 335–342that the activation of NF-κB by HBx protein might play a critical role
in the transcriptional induction of inﬂammatory genes and HBx-
induced chemotaxis. These ﬁndings provide a better understanding
of the regulation of leukocyte migration to liver after HBV infection,
and develop novel therapeutic targets and strategies for the
treatment of the disease.
Experimental procedures
Cell culture
Human hepatocellular carcinoma cells (HepG2) were cultured in
Dulbecco's modiﬁed Eagle medium (DMEM) supplemented with 10%
FBS, 100 μg/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a 5%
CO2 incubator.
Plasmid constructions
A 1026-bpMIG promoter construct (−983/+33)MIG, corresponding
to the sequence from −983 to +33 (relative to the transcriptional start
site) of the 5′-ﬂanking region of the human MIG gene, was generated
from human genomic DNA using F1 (5′-TTTCGAGCTCAAGTCCACAC-
CAACATCTG-3′) and R1 (5′-TCGCAAGCTTAGAATGGAGTTCCAAGTCAC-
3′) for forward and reverse primers incorporating SacI and HindIII
sites at 5′ and 3′-ends, respectively. The polymerase chain reaction
(PCR) product was cloned into SacI and HindIII sites of pGL3-Basic
vector. The resulting construct was conﬁrmed by DNA sequencing. The
5′-ﬂanking deletion constructs of the MIG promoter, (−495/+33)MIG,
(−185/+33)MIG, (−129/+33)MIGwere similarly generated by using the
(−983/+33)MIG construct as a template and the forward primers were
F2 (5′-TGTAGAGCTCCCAGAGGAAATTAAGGT-3′), F3 (5′-TTACGAGCT-
CATGCAGAAATTCCCT-3′) and F4 (5′-TGTCGAGCTCTGGTCAATTTAGT-
TAG-3′). Site-directed mutagenesis of two NF-κB sites and c/eBP site
was done bymultiple rounds of PCR using (−495/+33)MIG construct as
a template and appropriate primers with altered bases. The primers
used to make c/eBP mutant were: pair 1, F2 and R2(5′-CCTAAACTCTG-
gTTcGCTAGTATCTT-3′); pair 2, F5(5′-AAGATACTAGCgAAcCAGAG-
TTTAGG-3′) and R1. For mutating the NF-κB1 site, the primers were:
F6(5′-ACATGCAtAAATTCaCTTGGATCTG-3′) and R3(5′-CAGATCCAAGt-
GAATTTaTGCATGT-3′). For mutating the NF-κB2 site, the primers
were: F7(5′-GAGACTAGaGTTTCCtCCAGCACAAT-3′) and R4(5′-
ATTGTGCTGGaGGAAACtCTAGTCTC-3′). The ﬁrst two rounds of PCR
generated two fragments of DNA, with 25 bp of overlap. These two
fragments were gel puriﬁed and used as the templates for a third PCR
with F2 and R1 primers. The mutated DNA was then subcloned in
pGL3-Basic and veriﬁed by sequence analysis.
The expression vectors containing individual seven viral structural
genes of HBV and NF-κB subunits (p65 and p50) were a generous gift
of Dr. Wu Jianguo (Wuhan University, Wuhan, People's Republic of
China).
Transient transfections
HepG2 cells were plated at a density of 1×105 cell/well in a 24-well
plate. After 12–24h, cellswere co-transfectedwith 0.6 μg of expression
vector plasmids, 0.18 μg of promoter reporter plasmids, and 0.02 μg of
the pRL-TK plasmids using lipofectamine 2000 (Invitrogen, USA)
according to the manufacturer's instructions. After 5 h of transfection,
cells were washed and allowed to recover overnight in fresh medium
supplementedwith 1% FBS for 48 h. Serum-starved cells were used for
the assay.
Luciferase reporter gene activity assay
Luciferase activity was detected with the Dual Luciferase Assay
(Promega, USA) according the manufacturer's instructions. Brieﬂy, thetransfected cells were lysed in the culture dishes with the lysis buffer,
and the lysates were centrifuged at maximum speed for 1 min in an
Eppendorf microcentrifuge. The relative luciferase activity was
determined by a Modulus™ TD20/20 Luminometer (Turner Bio-
systems, USA), and transfection efﬁciency was normalized by Renilla
activity.
Enzyme-linked immunosorbent assay (ELISA)
Culture supernatants were assayed for MIG protein as manu-
facturer's instructions (JingMei, China) at room temperature. HepG2
cells were transfected with 0.8 μg of relative plasmids for 48 h. The
supernatants were then collected and assayed for MIG by ELISA. The
concentration ofMIGwas determined using a standard curve obtained
with recombinant MIG.
Western blot analysis
Nuclear and cytoplasmic proteins were prepared as previously
described (Kin and Fischer, 1998), fractionated by SDS-PAGE, and
transferred to nitrocellulose membranes. Nonspeciﬁc binding sites
were blocked with 5% milk in TBST (120 mM Tris–HCl, pH 7.4, 150 mM
NaCl, and 0.05% Tween 20) for 1 h at room temperature. Blots were
incubated with speciﬁc antibody overnight at 4 °C. The membranes
were washed three times and incubated with HRP-conjugated
secondary antibody. Proteins were visualized by Dura SuperSignal
Substrate (Pierce, USA).
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts were prepared from HepG2 cells according to the
methods described previously (Takenaka et al., 1994). Biotin end-
labeled oligonucleotides were synthesized and annealed to obtain
double-stranded DNA fragments. The oligonucleotide sequences were
as follows: 5′-CTAGGGTTTCCCCCAGCACAATC-3′ and 5′-GATTGTGCT-
GGGGGAAACCCTAG-3′. EMSA was performed using LightShift® Che-
miluminescent EMSAKit (Pierce, USA) according to themanufacturer's
protocol. Brieﬂy, DNA binding reactions were performed in 20 μl
samples containing 20 fmol Biotin-labeled oligonucleotides, 4 mg of
nuclear extracts, 2 mg of d(I–C), 2 μl 10×binding buffer, 0.1 mM EDTA,
and 10% glycerol at room temperature for 20 min. For supershift assay,
2 μl of polyclonal antibody directed against NF-kB subunits p50, p65,
p52, c-Rel or RelB (Santa Cruz, USA) was also added. For competitor
EMSA, 20-fold or 100-fold of unlabeled oligonucleotides was added
into the ﬁrst incubation, prior to the addition of labeled probe. The
mixture was incubated for 20min at room temperature. Samples were
run on 6% nondenaturing polyacrylamide gels with 0.5×TBE buffer
(25mMTris, pH 8.3; 190mMglycine; 1mMEDTA) and transferred to a
nylon membrane (Amersham Biosciences, Pharmacia, UK) at 380 mA
(∼100 V) for 30 min. A chemiluminescent detection method using a
luminal/enhancer solution and stable peroxide solution was used as
described by the manufacturer, and membranes were scanned by
Image Station 4000R (Kodak, USA).
Chromatin immunoprecipitation assay (ChIP)
HepG2 cells transfected with relative plasmids were cross-linked
using 1% formaldehyde at 37 °C for 10 min. After washing with PBS,
cells were resuspended in 300 μl lysis buffer (50 mM Tris, pH 8.1,
10 mM EDTA, 1% SDS, 1 mM PMSF). DNA was sheared to small
fragments by sonication. The supernatants were precleared using
herring sperm DNA/protein G-Sepharose slurry (Sigma-Aldrich, USA).
The recovered supernatants were incubated with anti-p50 antibody,
anti-p65 antibody or an isotype control IgG for 2 h in the presence of
herring sperm DNA and protein G-Sepharose beads. The immuno-
precipitated DNAwas retrieved from the beads with 1% SDS and 1.1 M
342 L.-M. Xia et al. / Virology 385 (2009) 335–342NaHCO3 solution at 65 °C for 6 h. DNA was then puriﬁed using a PCR
puriﬁcation kit (Qiagen, USA), and PCRwas done on the extracted DNA
using MIG promoter-speciﬁc primers: 5′-TTGGATCTGAGACTAGGGTT-
3′ and 5′-GCCTGAGAAATTCTTTAGAG-3′.
Migration assay
Migration assay was performed using 24-well Transwell plates
(Costar, USA). One milliliter of supernatants from the cells transfected
with relative plasmids was added to the lower chamber. IL-2-activated
PBLs (1×106) in 200 μl of RPMI medium were placed in the upper
chamber. Chambers were separated by a 5-μm-pore-size polycarbo-
nate membrane. The chambers were incubated for 4 h at 37 °C in 5%
CO2, and then the Transwell inserts were removed. Themigration cells
were stained and counted. To investigate the role of MIG in cell
migration, 10 μg of neutralizing anti-MIG antibody (Santa Cruz, USA)
per milliliter or isotype-matched control antibody (10 μg/ml) was
added 30 min prior to the onset of the migration assay. To investigate
the role of NF-κB in HBx-induced migration, HepG2 cells were
transfected with pCMV-HBx following treated with NF-κB inhibitor
MG-132 (Calbiochem, USA), and the migration assay was performed.
Statistical analysis
Data were expressed as means±SD of three determinations.
Statistical analysis data was analyzed using the Statistical Package
for Social sciences (SPSS) software (Version 11.0).
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